December 23, 2010 -- The ChinaBio® Investor Forum – Guangzhou selected two “Most Promising” companies out of the 20 young companies seeking investment. MingSight Pharmaceuticals was chosen in the drug category, and Cyagen Biosciences was named in the research tool group. The ChinaBio® event, which was held December 21, brought together more than 200 attendees, including over 50 international VCs and investors. More details....
